Juventus eye €18M-rated Bologna standout to fill Gleison Bremer’s void after injury

Bologna v Atalanta Serie A
Bologna v Atalanta Serie A / Ciancaphoto Studio/GettyImages
facebooktwitterreddit

Juventus defender Gleison Bremer will undergo surgery after tearing his anterior cruciate ligament during their UEFA Champions League clash with RB Leipzig, the club confirmed on Thursday.

The 27-year-old Brazilian was forced off just six minutes into Juve's 3-2 win over Leipzig on Wednesday, with Federico Gatti coming on to replace him.

In a statement, the club said: "Gleison Bremer and Nico Gonzalez underwent diagnostic tests ... which revealed an anterior cruciate ligament injury in Bremer's left knee and a low-grade injury to the rectus femoris in Gonzalez's right thigh. Bremer will undergo surgery in the coming days."

Since joining Juventus in 2022, Bremer has been a key figure in their defense, playing every minute of this Serie A season and helping the team keep clean sheets in all six matches.

Is Gleison Bremer's replacement on Juventus' radar?

According to Calciomercato, Juventus could turn to a familiar face, whom manager Thiago Motta knows, to replace the injured Gleison Bremer in January.

The report notes that Dutch center-back Sam Beukema, who Motta brought into the spotlight at Bologna last season, is said to be a top target on the list recently given to sporting director Cristiano Giuntoli.

The 25-year-old has been with the Serie A rival since 2023, making 41 appearances while scoring two goals and recording two assists. As for how much the player could cost, Transfermarkt puts the player's transfer value at €18 million.

It will be interesting to see what target Juventus decides to pursue to bolster their depth and ensure they don't miss Bremer's presence in the starting XI.

READ MORE:

Juventus reveals reported decision on Paul Pogba's future after drug ban suspension

Manchester United require major offer to entertain sale of Barcelona, Juventus-linked standout, report says

Fabrizio Romano confirms key development regarding Paul Pogba's drug ban